Attention Deficit Disorder with Hyperactivity: Clinical Trials

1,797 trials for Attention Deficit Disorder with Hyperactivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1154 completed, 254 unknown, 164 recruiting, 64 terminated. 788 Not applicable, 228 Phase 3, 225 Phase 4, 175 Phase 2, 78 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable788Completed 457, Unknown 126, Recruiting 98, Not yet recruiting 35, Active not recruiting 27, Terminated 17, Withdrawn 17, Enrolling by invitation 10, Suspended 1
Phase 3228Completed 191, Terminated 12, Recruiting 11, Withdrawn 6, Unknown 3, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Suspended 1
Phase 4225Completed 154, Unknown 27, Terminated 15, Recruiting 14, Withdrawn 10, Not yet recruiting 4, Active not recruiting 1
Phase 2175Completed 129, Unknown 18, Terminated 11, Recruiting 10, Not yet recruiting 3, Withdrawn 3, Enrolling by invitation 1
Phase 178Completed 57, Unknown 11, Recruiting 4, Terminated 3, Not yet recruiting 2, Enrolling by invitation 1
Early Phase 118Completed 11, Unknown 3, Enrolling by invitation 1, Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Attention Deficit Disorder with Hyperactivity: new trials by email Literature Review of Attention Deficit Disorder with Hyperactivity trials Research Report on Attention Deficit Disorder with Hyperactivity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CBT for Adult Inmates With ADHD
PROBECO, Formulation-based cognitive behavioral therapy - Attention Deficit Hyperactivity Disorder
Not applicableNot yet recruitingUniversidad Europea de Valencia1112027-09-012026-05-06
A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep
Ferrous Sulfate, Placebo - ADHD, Sleep Problems
Phase 1 / Phase 2Not yet recruitingHugo W. Moser Research Institute at Kennedy Krieger, Inc.702027-03-012026-05-04
Mentalization Orientated Psychoeducation Group for Adult ADHD (MOPAD)
The MOPAD study tests whether an introductory Mentalization-Based Treatment (iMBT) - ADHD - Attention Deficit Disorder With Hyperactivity
Not applicableNot yet recruitingSurrey and Borders Partnership NHS Foundation Trust162027-03-012026-11-10
Immersive Gamified Virtual Reality-Based Training for Children With Attention Deficit Hyperactivity Disorder
Immersive gamified virtual reality-based training (iGameVRT), Traditional social skills training - ADHD, Social Skills
Not applicableNot yet recruitingThe Hong Kong Polytechnic University1202027-01-022026-08-25
Novel Approaches to Supporting Students With ADHD in Multi-Tiered Systems of Support
Academic Competency Enhancement (ACE) classroom, School as Usual Classroom Supports - Attention Deficit Hyerpactivity Disorder
Phase 2 / Phase 3Not yet recruitingFlorida International University5442027-01-012026-09-28
Micronutrient Supplementation and Chronotherapy in Children With ADHD
Broad-spectrum multivitamin and mineral supplementation, Chronotherapy-Based Lifestyle Guidance - Attention Deficit Hyperactivity Disorder (ADHD)
Not applicableRecruitingUCSI University1202027-01-012026-11-06
Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD
Intermittent Theta-Burst Stimulation, Sham Stimulation - Attention Deficit Disorder With Hyperactivity
Not applicableNot yet recruitingVA Office of Research and Development352026-12-012026-10-02
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Psychotherapy - Disruptive Behavior Disorders, Conduct Disorder
RecruitingNational Institute of Mental Health (NIMH)2002026-11-182026-11-13
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Psychotherapy - Irritability, Disruptive Mood Dysregulation Disorder
RecruitingNational Institute of Mental Health (NIMH)4102026-11-182026-11-13
Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder
Delayed-release, extended-release methylphenidate, Placebo - ADHD, Cannabis Use Disorder
Phase 4Not yet recruitingMassachusetts General Hospital662026-11-012026-09-28
Developing Virtual Reality Programs to Address Social Skills Deficits in Youth With ADHD
VIP Suite - Attention-Deficit/Hyperactivity Disorder (ADHD)
Not applicableNot yet recruitingIndiana University482026-11-012026-10-20
Cognitive-Motor Training With the DextEgg in Children With ADHD
Cognitive-motor DextEgg training, Motor-only DextEgg training - Attention Deficit Hyperactivity Disorder (ADHD)
Not applicableNot yet recruitingManuela Pastore-Wapp502026-11-012026-11-05
Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance
EMPOWER-ND - Neurodevelopmental Disorders, Autism Spectrum Disorder (ASD)
Not applicableNot yet recruitingBoston University Charles River Campus502026-11-012026-10-27
Development and Evaluation of a Digital Game Intervention Targeting Children Vulnerable to ADHD
Digital Game Intervention, Tetris - ADHD or ADHD Traits
Not applicableNot yet recruitingThe Hong Kong Polytechnic University1002026-11-012026-10-28
Supporting Families of School-Aged Children With ADHD: A Dual-Generation Therapy Approach Through the BRIDGE Program
BRIDGE-ADHD - ADHD, Maternal Mental Health
Not applicableNot yet recruitingUniversity of Manitoba302026-11-012026-11-09
Phase 1: Thrive Together
Attention-Deficit/Hyperactivity Disorder (ADHD)
Not yet recruitingBoston Children's Hospital402026-10-312026-10-27
Development and Effectiveness of a Micro-Psychoeducation Program for Parents of Children With ADHD in Disaster Situations
articipants in the intervention group received the micro-psychoeducation program. - Parent Training, Psychoeducation
Not applicableNot yet recruitingKahramanmaras Sutcu Imam University602026-10-152026-08-20
Evaluation of Foquest in Adults 65 Years and Older With ADHD
Methylphenidate hydrochloride extended-release capsules - Attention Deficit Hyperactivity Disorder
Phase 4RecruitingDar Clinical Research Inc.362026-10-062026-10-07
Effectiveness and Security Testing of a Mobile App
Mobile app, Treatment as usual - Attention Deficit Disorder With Hyperactivity
Not applicableNot yet recruitingConsorci Sanitari del Maresme802026-10-012024-09-19
Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems
Brief video - Depression Disorders, ADHD
Not applicableNot yet recruitingNew York State Psychiatric Institute16002026-10-012026-09-03

Showing 20 of 1797. Sign in to see all of them.

Narrower conditions

Autism Spectrum Disorder (86)  ·  Anxiety Disorders (52)  ·  Spasm (46)  ·  Autistic Disorder (43)  ·  Oppositional Defiant Disorder (43)  ·  Neurodevelopmental Disorders (42)  ·  Depression (38)  ·  Conduct Disorder (34)  ·  Substance-Related Disorders (33)  ·  Bipolar Disorder (29)  ·  Impulsive Behavior (28)  ·  Attention Deficit and Disruptive Behavior Disorders (24)  ·  Mental Disorders (24)  ·  Motor Activity (21)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (1773)  ·  Mental Disorders (1773)  ·  Neurodevelopmental Disorders (1755)  ·  Nervous System Diseases (215)  ·  Behavior (178)  ·  Pathological Conditions, Signs and Symptoms (168)  ·  Signs and Symptoms (150)  ·  Neurologic Manifestations (134)  ·  Child Development Disorders, Pervasive (111)  ·  Behavioral Symptoms (69)  ·  Central Nervous System Diseases (66)  ·  Neurobehavioral Manifestations (65)  ·  Brain Diseases (61)  ·  Chemically-Induced Disorders (60)  ·  Neuromuscular Manifestations (46)

Interventions

Methylphenidate (217)  ·  Atomoxetine Hydrochloride (118)  ·  Lisdexamfetamine Dimesylate (66)  ·  Therapeutics (35)  ·  Guanfacine (29)  ·  Amphetamine (20)  ·  Dextroamphetamine (18)  ·  SLI381 (18)  ·  Transcranial Direct Current Stimulation (18)  ·  5,10-dihydro-5-methylphenazine (17)  ·  Cognitive Behavioral Therapy (16)  ·  1-(naphthalen-2-yl)-3-azabicyclo(3.1.0)hexane (14)  ·  Sugars (14)  ·  Control Groups (13)  ·  Dexmethylphenidate Hydrochloride (13)

Sponsors

Massachusetts General Hospital (64)  ·  Eli Lilly and Company (53)  ·  Shire (47)  ·  National Taiwan University Hospital (39)  ·  Children's Hospital Medical Center, Cincinnati (36)  ·  Karolinska Institutet (21)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (21)  ·  Supernus Pharmaceuticals, Inc. (21)  ·  Florida International University (20)  ·  Duke University (19)  ·  New York State Psychiatric Institute (18)  ·  National Institute of Mental Health (NIMH) (17)  ·  Hospital de Clinicas de Porto Alegre (14)  ·  NYU Langone Health (14)  ·  Assiut University (13)

Countries

United States (797)  ·  Canada (85)  ·  Israel (83)  ·  France (80)  ·  Taiwan (72)  ·  Germany (61)  ·  Sweden (60)  ·  United Kingdom (55)  ·  China (53)  ·  Turkey (Türkiye) (45)  ·  Netherlands (44)  ·  Spain (42)  ·  Italy (34)  ·  Hong Kong (32)  ·  Brazil (29)

Top investigators

Susan Shur-Fen Gau, MD, PhD (22)  ·  Joseph Biederman, MD (16)  ·  Ann Childress, MD (13)  ·  Jeffrey Newcorn, MD (8)  ·  Craig Surman, MD (7)  ·  Thomas Spencer, MD (6)  ·  Timothy Wilens, MD (6)  ·  Chi-Yung Shang, MD (5)  ·  Jonathan Rubin, MD (5)

Results publications

PMID 25019647, PMID 37058600, PMID 35201607, PMID 36971690, PMID 37811711, PMID 41342306, PMID 33600233, PMID 33971070, PMID 34523063, PMID 36847750, PMID 38824626, PMID 21569378, PMID 35690720, PMID 37120522, PMID 38685016, PMID 39128918, PMID 10385840, PMID 11394191, PMID 14595084, PMID 16671928, PMID 18777484, PMID 19318991, PMID 20215923, PMID 20861587, PMID 21156272, PMID 21367347, PMID 21432592, PMID 21824454, PMID 23137723, PMID 23356790, PMID 24290461, PMID 24636025, PMID 25266438, PMID 25877989, PMID 26745211, PMID 27082828, PMID 27118284, PMID 28576350, PMID 28980198, PMID 34057707, PMID 34468332, PMID 34637343, PMID 34714112, PMID 37093628, PMID 40527386, PMID 40975435, PMID 41697570, PMID 42779129, PMID 10433412, PMID 10560028

NIH funding

2023 (5), 2009 (3), R34MH101282 (3), 2008 (2), 2014 (2), 2015 (2), 2025 (2), K24DA016264 (2), R21MH124066 (2), R61MH113663 (2), R61MH131632 (2), U10DA013732 (2), 2017 (1), 2018 (1), 2019 (1)